Use of Flurbiprofen Ester in 4-Dimensional Hysterosalpingography: Does Flurbiprofen Ester Relieve Pain During an Infertility Evaluation?
article
OA: diamond
CC0
AI-generated summary
Intravenous flurbiprofen ester significantly reduced pain and adverse effects during and after transvaginal 4D hysterosalpingography for infertility evaluations.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Abstract Objective: The purpose of this study was to determine the analgesic effect of a flurbiprofen ester injection via continuous intravenous drip during transvaginal 4-dimensional hysterosalpingography (TVS 4D-HyCoSy). Methods: Two hundred thirty patients who underwent TVS 4D-HyCoSy for infertility from May 2018 to August 2021 at our hospital were selected. The participants were grouped based on tubal patency, flurbiprofen ester use, and uterine cannula diameter, as follows: bilateral tubal patency group; non-bilateral tubal patency group; atropine group; atropine + flurbiprofen ester group; coarse tube group; and fine tube group. The analgesic effect during TVS 4D-HyCoSy and pain relief were compared between groups using visual analog scoring (NRS). Additionally, the incidence of adverse effects was recorded and factors related to the influence of pain were analyzed. Results: 1. Tubal patency reduced pain during ultrasound tubal examination, flurbiprofenate provided significant analgesia after ultrasound tubalography and reduced adverse effects ( P < 0.001). 2. The tube diameter thickness had no effect on tubal ultrasonography procedure-related pain. 3. Multivariable analysis of pain relief during imaging suggested that the use of flurbiprofen for bilateral tubal patency had a significant positive effect on pain relief within 30 min after the examination with an AUC of 0.732 (95% CI: 0.665–0.798). Conclusion: A flurbiprofen ester continuous intravenous drip had a good analgesic effect in patients with TVS 4D-HyCoSy. Specifically, the pain relief effect after examination was significant and reduced the incidence of adverse reactions during the contrast examination. Flurbiprofen ester can be administered independently and is worthy of clinical promotion and application.
My notes (saved in your browser only)
Outcome instruments
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
- Female Infertility: A Systematic Approach to Radiologic Imaging and Diagnosis 2009
- The Effect of Flurbiprofen as Prophylactic Analgesic before Hysterosalpingography 2010
- Information seeking and perceptions of anxiety and pain among women undergoing hysterosalpingography 2016
- Hysterosalpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency in endometriosis patients 2014
References (23)
- Female Infertility: A Systematic Approach to Radiologic Imaging and Diagnosis via openalex
- Hysterosalpingo-contrast-sonography (HyCoSy) in the assessment of tubal patency in endometriosis patients via openalex
- Information seeking and perceptions of anxiety and pain among women undergoing hysterosalpingography via openalex
- The Effect of Flurbiprofen as Prophylactic Analgesic before Hysterosalpingography via openalex
- W2055100482 via openalex
- W2071267067 via openalex
- W2071930426 via openalex
- W2075182570 via openalex
- W2082853149 via openalex
- W2143781681 via openalex
- W2143903912 via openalex
- W2166860228 via openalex
- W2470382955 via openalex
- W2561745345 via openalex
- W2586595104 via openalex
- W2770942517 via openalex
- W2971542523 via openalex
- W2985346725 via openalex
- W3000010346 via openalex
- W3094591729 via openalex
- W1982569396 via openalex
- W3112184374 via openalex
- W1997481242 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK